BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38426285)

  • 21. Knock-in of the
    Annesley CE; Rabik C; Duffield AS; Rau RE; Magoon D; Li L; Huff V; Small D; Loeb DM; Brown P
    Oncotarget; 2018 Oct; 9(82):35313-35326. PubMed ID: 30450160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
    Owattanapanich W; Herzig J; Jahn N; Panina E; Ruchutrakool T; Kungwankiattichai S; Issaragrisil S; Döhner H; Döhner K
    Ann Hematol; 2021 Aug; 100(8):1983-1993. PubMed ID: 33839881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
    Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
    Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia.
    Jamal R; Taketani T; Taki T; Bessho F; Hongo T; Hamaguchi H; Horiike S; Taniwaki M; Hanada R; Nakamura H; Hayashi Y
    Genes Chromosomes Cancer; 2001 Jun; 31(2):187-90. PubMed ID: 11319806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
    Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
    Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.
    Meshinchi S; Woods WG; Stirewalt DL; Sweetser DA; Buckley JD; Tjoa TK; Bernstein ID; Radich JP
    Blood; 2001 Jan; 97(1):89-94. PubMed ID: 11133746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
    Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
    Blood Adv; 2021 Feb; 5(3):900-912. PubMed ID: 33560403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.
    Al-Arbeed IF; Wafa A; Moassass F; Al-Halabi B; Al-Achkar W; Abou-Khamis I
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3245-3251. PubMed ID: 34711001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-lineage level-targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes.
    Yokoyama K; Shimizu E; Yokoyama N; Nakamura S; Kasajima R; Ogawa M; Takei T; Ito M; Kobayashi A; Yamaguchi R; Imoto S; Miyano S; Tojo A
    Blood Adv; 2018 Oct; 2(19):2513-2521. PubMed ID: 30282643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling
    Molina Garay C; Carrillo Sánchez K; Flores Lagunes LL; Jiménez Olivares M; Muñoz Rivas A; Villegas Torres BE; Flores Aguilar H; Núñez Enríquez JC; Jiménez Hernández E; Bekker Méndez VC; Torres Nava JR; Flores Lujano J; Martín Trejo JA; Mata Rocha M; Medina Sansón A; Espinoza Hernández LE; Peñaloza Gonzalez JG; Espinosa Elizondo RM; Flores Villegas LV; Amador Sanchez R; Pérez Saldívar ML; Sepúlveda Robles OA; Rosas Vargas H; Rangel López A; Domínguez López ML; García Latorre EA; Reyes Maldonado E; Galindo Delgado P; Mejía Aranguré JM; Alaez Verson C
    Front Pediatr; 2020; 8():586. PubMed ID: 33042924
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients.
    Wang L; Lin D; Zhang X; Chen S; Wang M; Wang J
    Leuk Res; 2005 Dec; 29(12):1393-8. PubMed ID: 15996732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FLT3 mutations at diagnosis and relapse in acute myeloid leukemia: cytogenetic and pathologic correlations, including cuplike blast morphology.
    McCormick SR; McCormick MJ; Grutkoski PS; Ducker GS; Banerji N; Higgins RR; Mendiola JR; Reinartz JJ
    Arch Pathol Lab Med; 2010 Aug; 134(8):1143-51. PubMed ID: 20670134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia.
    Ambinder AJ; DeZern AE
    Front Oncol; 2022; 12():1033534. PubMed ID: 36387170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
    Tarlock K; Gerbing RB; Ries RE; Smith JL; Leonti A; Huang BJ; Kirkey D; Robinson L; Peplinksi JH; Lange B; Cooper TM; Gamis AS; Kolb EA; Aplenc R; Pollard JA; Alonzo TA; Meshinchi S
    Blood Adv; 2024 May; 8(9):2094-2103. PubMed ID: 38295280
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Giudice V; Gorrese M; Vitolo R; Bertolini A; Marcucci R; Serio B; Guariglia R; Ferrara I; Pepe R; D'Alto F; Izzo B; Pedicini A; Montuori N; Langella M; Selleri C
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.